TBXT and Alzheimer disease: Amyloid pathology, in the absence of τ or neurodegenerative pathology, defines preclinical AD and is the first step along the Alzheimer’s continuum in humans (Vickers et al, 2016; Jack et al, 2018; Cummings, 2019).